Showing results (291-300 of 1,003) with videos related to

Sort By:
Pageof 101
Cardiovascular Therapeutics|December 29, 2017
Exenatide exhibits anti-inflammatory properties and modulates endothelial response to tumor necrosis factor α-mediated activationWojciech Garczorz, Enrique Gallego-Colon, Agnieszka Kosowska, et al.
Cardiovascular Therapeutics|October 21, 2018
Effects of serial phlebotomy on vascular endothelial function: Results of a prospective double-blind randomized studyQurat-Ul-Ain Jelani, Bhisham Harchandani, Ritchard G Cable, et al.
Cardiovascular Therapeutics|October 30, 2018
The modifying effect of the MTHFR genotype on the association between folic acid supplementation and pulse wave velocity: Findings from the CSPPTXin Yang, Minghua Zhang, Rensheng Song, et al.
Cardiovascular Therapeutics|April 20, 2017
RVX 208: A novel BET protein inhibitor, role as an inducer of apo A-I/HDL and beyondGopal C Ghosh, Rajarshi Bhadra, Raktim K Ghosh, et al.
Cardiovascular Therapeutics|November 19, 2016
Ezetimibe: Use, costs, and adverse events in AustraliaSamantha A Hollingworth, Remo Ostino, Michael C David, et al.
Cardiovascular Therapeutics|November 19, 2016
Efficacy and safety of two dosages of canrenone as add-on therapy in hypertensive patients taking ace-inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE-IT trialGiuseppe Derosa, Pamela Maffioli, Maria D'Avino, et al.
Cardiovascular Therapeutics|October 30, 2016
Platelet activating factor: A potential biomarker in acute coronary syndrome?Anand Vijaya Kumar Palur Ramakrishnan, Treesa P Varghese, Sreedevi Vanapalli, et al.
Cardiovascular Therapeutics|November 26, 2016
Extended dual antiplatelet therapy after acute coronary syndrome in Spain: Results from the EPICOR studyAlfredo Bardají, Manuel Leal, Vicente Arrarte, et al.
Cardiovascular Therapeutics|December 14, 2016
Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS studyAlberto Cordero, Luis Rodriguez Padial, Alberto Batalla, et al.
Cardiovascular Therapeutics|December 14, 2016
Protective effects of low-dose rosuvastatin on isoproterenol-induced chronic heart failure in rats by regulation of DDAH-ADMA-NO pathwayRu Zhou, Ping Ma, Aiqin Xiong, et al.
Pageof 101